Minimal change disease associated with MALT lymphoma

International Urology and Nephrology

Volumn 44, Issue 6, 2012, Pages 1911-1913

  Kasmani, Rahil ^a   Marina, Vamsee Priya ^a   Abidi, Syed ^b   Johar, Bikram ^b   Malhotra, Deepak ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b ST VINCENT MERCY MEDICAL CENTER   (United States)

Author keywords

Lymphoma; Minimal change; Rituximab

Indexed keywords

ALBUMIN; CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; CHOLESTEROL; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CREATININE; CYCLIN D1; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; LEUKOSIALIN; NITROGEN; RITUXIMAB; UREA;

ABDOMINAL RADIOGRAPHY; ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GALLSTONE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; KIDNEY BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; MARGINAL ZONE LYMPHOMA; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; NEPHROTIC SYNDROME; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WEIGHT GAIN; LIPOID NEPHROSIS; MIDDLE AGED;

HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEPHROSIS, LIPOID;

EID: 84877605453     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9992-z     Document Type: Article

References (17)

1. Audard V, Larousserie F, Grimbert P, et al. (2006) Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. Kidney Int 69(12):2251-2260
2. Baizhou L, Zhang W, Tian X, Qiu L (2008) Primary renal mucosa-associated lymphoid tissue lymphoma, the result of chronic pyelonephritis? Chin-Ger J Clin Oncol 7(1):55-58
3. Tao J, Kahn L (2000) Epstein-Barr virus-associated high-grade B-cell lymphoma of mucosal-associated lymphoid tissue in a 9-year-old boy. Arch Pathol Lab Med 124(10):1520-1524
4. Colović M, Hadzi-Djokić J, Cemerikić V, Colović R, Janković G, Dacić M (1999) Primary MALT lymphoma of the kidney. Hematol Cell Ther 41(5):229-232
5. Pelstring RJ, Essell JH, Kurtin PJ, Cohen AR, Banks PM (1991) Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues. Am J Clin Pathol 96(6):738-745
6. Mak SK, Wong PN, Lo KY, Wong AK (1998) Successful treatment of IgA nephropathy in association with low-grade B-cell lymphoma of the mucosa-associated lymphoid tissue type. Am J Kidney Dis 31(4):713-718
7. Stokes MB, Wood B, Alpers C (2002) Membranoproliferative glomerulonephritis associated with low-grade B cell lymphoma presenting in the kidney. Clin Nephrol 57(4):303-309
8. Garcia M, Konoplev S, Morosan C, Abruzzo LV, Bueso-Ramos CE, Medeiros LJ (2007) MALT lymphoma involving the kidney: a report of 10 cases and review of the literature. Am J Clin Pathol 128(3):464-473
9. Alpers CE, Cotran RS (1986) Neoplasia and glomerular injury. Kidney Int 30(4):465-473
10. Ronco PM (1999) Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56(1):355-377
11. Dabbs DJ, Striker LM, Mignon F, Striker G (1986) Glomerular lesions in lymphomas and leukemias. Am J Med 80(1):63-70
12. Ghosh L, Muehrcke RC (1970) Nephrotic syndrome: a prodrome to lymphoma. Ann Intern Med 72(3):379-382
13. Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD (1976) The nephrotic syndrome associated with neoplasia: an unusual paraneoplastic syndrome. Report of a case and review of the literature. Am J Med 60(7):1026-1031
14. Aggarwal N, Batwara R, McCarthy ET, Sharma R, Sharma M, Savin VJ (2007) Serum permeability activity in steroid-resistant minimal change nephrotic syndrome is abolished by treatment of Hodgkin disease. Am J Kidney Dis 50(5):826-829
15. Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21(11):1698-1700
16. Yang T, Nast CC, Vo A, Jordan SC (2008) Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy. Nephrol Dial Transplant 23(1):377-380
17. Deschênes G, Doucet A (2009) Free immunoglobulin light chains: a role in minimal change disease. Biosci Hypothesis 2(3):135-142